Nifekalant is under investigation in clinical trial NCT03855826 (Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection).
用于其它抗心率失常药无效或不耐受的严重的室性心率失常、室颤患者的治疗。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.